Good day, ladies and gentlemen. Welcome to the Progyny, Inc. Fourth Quarter Earnings Conference Call. At this time all participants are in a listen-only mode. The floor will be opened for ...

Cash and Equivalents (End of 2024): $228 million, with no debt. Progyny Inc (NASDAQ:PGNY) reported revenue and adjusted EBITDA for the fourth quarter above the high end of their guidance ranges.

Progyny, Inc. (($PGNY)) has held its Q4 earnings call. Read on for the main highlights of the call. Progyny, Inc. recently held its earnings call, ...

and issue a press release regarding its financial results prior to the start of the call. In Progyny (PGNY) might move higher on growing optimism about its earnings prospects, which is reflected ...

The market expects Progyny (PGNY) to deliver a year-over-year increase in earnings on higher revenues ... of business conditions on theearnings call it's worth handicapping the probability of ...

Shares of NASDAQ PGNY opened at $23.20 on Monday ... The stock has a market cap of $1.98 billion, a PE ratio of 40.00, a price-to-earnings-growth ratio of 2.39 and a beta of 1.34.

Progyny Inc . (NASDAQ:PGNY) reported strong financial results for Q4 2024, significantly surpassing earnings and revenue forecasts. The company posted an earnings per share (EPS) of $0.42, ...

Fertility benefits company Progyny (NASDAQ:PGNY) will be announcing earnings results tomorrow after market close. Here’s what investors should know. Progyny missed analysts’ revenue ...

Cash and Equivalents (End of 2024): $228 million, with no debt. Progyny Inc (NASDAQ:PGNY) reported revenue and adjusted EBITDA for the fourth quarter above the high end of their guidance ranges. The ...

The market expects Progyny (PGNY) to deliver a year-over-year increase in earnings ... will mostly depend on management's discussion of business conditions on the earnings call, it's worth ...